Notice of Intent to issue a Sole Source Award to support development and validation of novel ARV detection methods.

Closed Pre-Solicitation Posted

Solicitation number
75D30126R73456
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Atlanta, Georgia 30322, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Centers for Disease Control and Prevention Division of HIV Prevention intends to award a sole source firm fixed price purchase order to Emory University for development and validation of novel antiretroviral (ARV) detection methods, with responses due by June 2, 2026. The Government is proceeding under FAR 12.102-1 (commercial services, single-source justification) and does not anticipate a competitive solicitation.

Emory University will collect freshly matched biological specimens—whole blood and urine—from individuals receiving ARVs for HIV treatment or prevention and from individuals not receiving ARVs to serve as assay controls. Specimens must be delivered to CDC's Laboratory Branch within 24 hours of collection. CDC will evaluate the specimens using research-use-only (RUO) assays employing novel methods for measuring ARVs, assessing whether results are consistent with LC-MS-MS output and evaluating practical factors including sample extraction and turnaround time to guide next-stage development of these detection tools.

The Government's sole-source justification identifies Emory University as the only capable source: it is the sole entity that can deliver freshly collected specimens within a few hours without compromising specimen integrity, and no other companies or state-licensed medical clinics are located within reasonable distance of CDC to perform the required work.

This notice is not a competitive quotation request, but the Government will consider all responses received within 15 days. Award determination remains at the Government's discretion. The procurement falls under NAICS 541715 (Medical research and development laboratories or services) and PSC AJ12 (General Science and Technology R&D Services).

Notice text

The Centers for Disease Control and Prevention Division of HIV Prevention (DHP)/Laboratory Branch (LB) intends to award a sole source firm fixed price purchase order to Emory University to support development and validation of novel ARV detection methods by obtaining freshly collected, matched biological specimens from individuals receiving ARVs for HIV treatment or prevention, and from individuals not receiving ARVs for developing assay controls. Emory University will collect fresh matched samples of whole blood and urine within the project timeline and deliver to CDC DHP Laboratory Branch staff within 24 hours of specimen collection to allow for CDC’s analysis using research use only (RUO) assays that employ novel methods for measuring ARVs. CDC is assessing novel assays to provide results consistent with those obtained by LC-MS-MS, as well as the convenience of the assays (sample extraction, time to run, etc.) to inform the next stages of development for these innovative tools.  This contract action is for commercial services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 12.102-1. NAICS 541715 - Medical research and development laboratories or services (except biotechnology and nanotechnology research and development). Emory University is the only source that can deliver freshly collected biological specimens within a few hours, without compromising the integrity of the specimens as required.  There are no other companies or state licensed medical clinics located within a resonable distance from the CDC to provide the services described above.  This notice of intent is not a request for competitive quotations; however, all Quotations/ responses received within 15 days of the issuance of this notice shall be considered by the government.  A determination by the government not to complete this proposed contract based upon responses to this notice is solely within the discretion of the government.  Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.  Any quotation/response should be emailed to the contract specialist at email zvm0@cdc.gov by 06/02/2026.

Similar open opportunities

Opportunity Agency Set-aside Responses due
1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) Bethesda, Maryland 20892, United States · NAICS 811210 National Institute of Allergy and Infectious Diseases No set-aside
Notice of Intent to Sole Source a Thermo Orbitrap Fusion Lumos and Thermo RSLCnano UPLC Maintenance Agreement Georgia 30329, United States · NAICS 811210 CDC Office of Acquisition Services No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors